^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CT071

    i
    Other names: CT071, CT 071, CT-071
    Associations

    News

    Trials
    Company:
    CARsgen
    Drug class:
    GPRC5D-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    5ms
    Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma (clinicaltrials.gov)
    P1, N=10, Recruiting, Shanghai Changzheng Hospital | Not yet recruiting --> Recruiting
    Enrollment open
    |
    CT071
    5ms
    Study of CT071 Injection in RRMM or PPCL (clinicaltrials.gov)
    P1, N=30, Recruiting, Shanghai Changzheng Hospital | N=18 --> 30
    Enrollment change
    |
    CT071
    6ms
    Study of CT071 Injection in HRNDMM (clinicaltrials.gov)
    P1, N=10, Not yet recruiting, Shanghai Changzheng Hospital
    New P1 trial
    |
    CT071
    8ms
    Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL (clinicaltrials.gov)
    P1/2, N=166, Not yet recruiting, CARsgen Therapeutics Co., Ltd.
    New P1/2 trial • CAR T-Cell Therapy
    |
    CT071
    over1year
    Study of CT071 Injection in RRMM or PPCL (clinicaltrials.gov)
    P1, N=18, Recruiting, Shanghai Changzheng Hospital | Not yet recruiting --> Recruiting
    Enrollment open
    |
    CT071